Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 220

1.

Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.

Clothier HJ, Crawford N, Russell MA, Buttery JP.

Euro Surveill. 2017 May 18;22(20). pii: 30535. doi: 10.2807/1560-7917.ES.2017.22.20.30535.

2.

Empiric antibiotic regimens for neonatal sepsis in Australian and New Zealand neonatal intensive care units.

Carr JP, Burgner DP, Hardikar RS, Buttery JP.

J Paediatr Child Health. 2017 Jul;53(7):680-684. doi: 10.1111/jpc.13540. Epub 2017 Apr 19.

PMID:
28421643
3.

Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.

Clothier HJ, Crawford NW, Russell M, Kelly H, Buttery JP.

Drug Saf. 2017 Jun;40(6):483-495. doi: 10.1007/s40264-017-0520-7.

PMID:
28342074
4.

A quality improvement initiative to reduce central line infection in neonates using checklists.

Taylor JE, McDonald SJ, Earnest A, Buttery J, Fusinato B, Hovenden S, Wallace A, Tan K.

Eur J Pediatr. 2017 May;176(5):639-646. doi: 10.1007/s00431-017-2888-x. Epub 2017 Mar 10.

PMID:
28283785
5.

Kawasaki disease and immunisation: A systematic review.

Phuong LK, Bonetto C, Buttery J, Pernus YB, Chandler R, Felicetti P, Goldenthal KL, Kucuku M, Monaco G, Pahud B, Shulman ST, Top KA, Trotta F, Ulloa-Gutierrez R, Varricchio F, de Ferranti S, Newburger JW, Dahdah N, Singh S, Bonhoeffer J, Burgner D; Brighton Collaboration Kawasaki Disease (KD) Working Group.

Vaccine. 2017 Mar 27;35(14):1770-1779. doi: 10.1016/j.vaccine.2016.09.033. Epub 2017 Mar 2.

PMID:
28259442
6.

Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis.

Phuong LK, Bonetto C, Buttery J, Pernus YB, Chandler R, Goldenthal KL, Kucuku M, Monaco G, Pahud B, Shulman ST, Top KA, Ulloa-Gutierrez R, Varricchio F, de Ferranti S, Newburger JW, Dahdah N, Singh S, Bonhoeffer J, Burgner D; Brighton Collaboration Kawasaki Disease (KD) Working Group.

Vaccine. 2016 Dec 12;34(51):6582-6596. doi: 10.1016/j.vaccine.2016.09.025. Epub 2016 Nov 15. No abstract available.

PMID:
27863715
7.

Options for improving effectiveness of rotavirus vaccines in developing countries.

Tissera MS, Cowley D, Bogdanovic-Sakran N, Hutton ML, Lyras D, Kirkwood CD, Buttery JP.

Hum Vaccin Immunother. 2017 Apr 3;13(4):921-927. doi: 10.1080/21645515.2016.1252493. Epub 2016 Nov 11. Review.

PMID:
27835052
8.

Global alignment of immunization safety assessment in pregnancy - The GAIA project.

Bonhoeffer J, Kochhar S, Hirschfeld S, Heath PT, Jones CE, Bauwens J, Honrado Á, Heininger U, Muñoz FM, Eckert L, Steinhoff M, Black S, Padula M, Sturkenboom M, Buttery J, Pless R, Zuber P; GAIA project participants.

Vaccine. 2016 Dec 1;34(49):5993-5997. doi: 10.1016/j.vaccine.2016.07.006. Epub 2016 Oct 14.

9.

Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data.

Quinn JA, Munoz FM, Gonik B, Frau L, Cutland C, Mallett-Moore T, Kissou A, Wittke F, Das M, Nunes T, Pye S, Watson W, Ramos AA, Cordero JF, Huang WT, Kochhar S, Buttery J; Brighton Collaboration Preterm Birth Working Group.

Vaccine. 2016 Dec 1;34(49):6047-6056. doi: 10.1016/j.vaccine.2016.03.045. Epub 2016 Oct 13.

10.

Antenatal pertussis vaccination: Are we implementing best evidence into practice?

Krishnaswamy S, Wallace E, Buttery J, Giles M.

Aust N Z J Obstet Gynaecol. 2016 Dec;56(6):552-555. doi: 10.1111/ajo.12554. Epub 2016 Oct 5. Review.

PMID:
27704540
11.

Epidemiology and Mortality of Staphylococcus aureus Bacteremia in Australian and New Zealand Children.

McMullan BJ, Bowen A, Blyth CC, Van Hal S, Korman TM, Buttery J, Voss L, Roberts S, Cooper C, Tong SY, Turnidge J.

JAMA Pediatr. 2016 Oct 1;170(10):979-986. doi: 10.1001/jamapediatrics.2016.1477.

PMID:
27533601
12.

Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.

Vergnano S, Buttery J, Cailes B, Chandrasekaran R, Chiappini E, Clark E, Cutland C, de Andrade SD, Esteves-Jaramillo A, Guinazu JR, Jones C, Kampmann B, King J, Kochhar S, Macdonald N, Mangili A, de Menezes Martins R, Velasco Muñoz C, Padula M, Muñoz FM, Oleske J, Sanicas M, Schlaudecker E, Spiegel H, Subelj M, Sukumaran L, Tagbo BN, Top KA, Tran D, Heath PT; Brighton Collaboration Neonatal Infections Working Group.

Vaccine. 2016 Dec 1;34(49):6038-6046. doi: 10.1016/j.vaccine.2016.03.046. Epub 2016 Aug 1.

13.

Adverse events following HPV immunization in Australia: Establishment of a clinical network.

Crawford NW, Hodgson K, Gold M, Buttery J, Wood N; AEFI-CAN network.

Hum Vaccin Immunother. 2016 Oct 2;12(10):2662-2665. doi: 10.1080/21645515.2016.1192737. Epub 2016 Jun 13.

14.

Don't aim too high: Avoiding shoulder injury related to vaccine administration.

Cross GB, Moghaddas J, Buttery J, Ayoub S, Korman TM.

Aust Fam Physician. 2016 May;45(5):303-6.

15.

Human papillomavirus vaccination and primary ovarian insufficiency: an association based on ideology rather than evidence.

Hawkes D, Buttery JP.

Curr Opin Obstet Gynecol. 2016 Feb;28(1):70-2. doi: 10.1097/GCO.0000000000000240. No abstract available.

PMID:
26642064
16.

Australian Rotavirus Surveillance Program annual report, 2014.

Kirkwood CD, Roczo-Farkas S; Australian Rotavirus Surveillance Group.

Commun Dis Intell Q Rep. 2015 Sep 30;39(3):E337-46.

17.

Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015.

Pillsbury A, Cashman P, Leeb A, Regan A, Westphal D, Snelling T, Blyth C, Crawford N, Wood N, Macartney K; AusVaxSafety, surveillance team.

Euro Surveill. 2015;20(43). doi: 10.2807/1560-7917.ES.2015.20.43.30050.

18.

Human Papillomavirus (HPV) Vaccination Safety Assessment: The Methods Matter.

Brotherton JM, Macartney KK, Miyagi E, Buttery JP.

Intern Med. 2015;54(19):2531. doi: 10.2169/internalmedicine.54.4643. Epub 2015 Oct 1. No abstract available.

19.

Cat scratch disease of the parotid gland.

Hollitt A, Buttery J, Carr J, Chan Y, Ditchfield M, Burgner D.

Arch Dis Child. 2016 Jan;101(1):63-4. doi: 10.1136/archdischild-2015-309318. Epub 2015 Sep 24. No abstract available.

PMID:
26403943
20.

Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial.

Bines JE, Danchin M, Jackson P, Handley A, Watts E, Lee KJ, West A, Cowley D, Chen MY, Barnes GL, Justice F, Buttery JP, Carlin JB, Bishop RF, Taylor B, Kirkwood CD; RV3 Rotavirus Vaccine Program.

Lancet Infect Dis. 2015 Dec;15(12):1389-97. doi: 10.1016/S1473-3099(15)00227-3. Epub 2015 Aug 26.

PMID:
26318715

Supplemental Content

Loading ...
Support Center